By ANDREW POLLACK
While not as advantageous as an inversion, biotech players are saving on taxes by transferring patents to foreign subsidiaries.
Published: September 30, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1BxEfaS
via IFTTT
from WordPress http://ift.tt/1wSAz2H
No comments:
Post a Comment